medigraphic.com
ISSN 1561-3062 (Electronic)

2016, Number 1

<< Back Next >>

Revista Cubana de Obstetricia y Ginecología 2016; 42 (1)

Management of cytomegalovirus infections and herpes simplex virus in pregnant women and newborns

Festary CA, Kourí CV

Language: Spanish
References: 25
Page:
PDF size: 118.62 Kb.


ABSTRACT

There is a group of infections, which can cause serious birth defects when acquired during pregnancy. They affect infant morbidity and mortality, especially if the infection occurs before 20 weekspregnant. These include those caused by cytomegalovirus and herpes simplex virus that are often associated with congenital infection and damage to the newborn.Human cytomegalovirus (HCMV)is globally distributed among human populations from developed countries to Aboriginal communities. In developing and low socioeconomic strata of the developed countries, the prevalence is higher (over 90 %) and the virus is acquired in earlier stages of life. It is the most common congenital viral infection. It occurs 0.3 to 2 % of births and 40 % transmission is vertical. The distribution of herpes simplex virus is broad and seroprevalence in adults is between 60 and 75 % for herpes simplex 1 virus and 11-30 % for herpes simplex virus -2. The aim of this review is to describe these two entities in addressing the most common features of these conditions as epidemiology, diagnosis, clinical and therapeutic. A profound knowledge is necessary for the attending physician to the proper handling of them.


REFERENCES

  1. Revello MG, Gema G. Diagnosis and management of Human cytomegalovirus infections in the mother, fetus and newborn infant. Clinical Microbiology Reviews. 2002;15(4):680-15.

  2. Abo-Elwafa HA, Eldin SS, Sharaf AE, Abdelmonem AM. Serological markers as indicators for congenital cytomegalovirus infection. Egypt J Immunol. 2010;17(2):1- 10. Epub 2010/01/01.

  3. Senok AC, Giacomett IL, Botta G. Human cytomegalovirus infections in pregnancy and the newborn: epidemiology, laboratory diagnosis and medico legal aspects. Kuwait Medical Journal. 2006;38(2):85-93.

  4. Saraswathy TS, Az-Ulhusna A, Asshikin RN, Suriani S, Zainah S. Seroprevalence of cytomegalovirus infection in pregnant women and associated role in obstetric complications: a preliminary study. Southeast Asian J Trop Med Public Health. 2011;42(2):320-2. Epub 2011/06/30.

  5. Gaj Z, Rycel M, Wilczynski J, Nowakowska D. Seroprevalence of cytomegalovirus infection in the population of Polish pregnant women. Ginekol Pol. 2012;83(5):337-41. Epub 2012/06/20.

  6. Perez-Sola MJ, Caston JJ, Solana R, Rivero A, Torre Cisnero J. Indirect effects of cytomegalovirus infection in solid organ transplant recipients. Enferm Infecc Microbiol Clin. 2008;26(1):38-47.

  7. van der Weiden S, de Jong EP, Te Pas AB, Middeldorp JM, Vossen AC, Rijken M, et al. Is routine TORCH screening and urine CMV culture warranted in small for gestational age neonates? Early Hum Dev. 2011;87(2):103-7. Epub 2010/12/15.

  8. Bagheri L, Mokhtarian H, Sarshar N, Ghahramani M. Seroepidemiology of cytomegalovirus infection during pregnancy in Gonabad, east of Iran: a cross-sectional study. Journal of research in health sciences. 2012;12(1):38-44. Epub 2012/08/15.

  9. Enders G, Daiminger A, Bader U, Exler S, Enders M. Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age. J Clin Virol. 2011;52(3):244-6. Epub 2011/08/09.

  10. Ho M.The history of cytomegalovirus and its deseases. Med Microbiol Immunol. 2007;197(2):65-73.

  11. Jin Choi S, Deok Park S, Ho Jang I, Uh Y, Lee A. The Prevalence of Vaginal Microorganisms in Pregnant Women with Preterm Labor and Preterm Birth. Annals of laboratory medicine. 2012;32(3):194-200.

  12. Britt W. Human Cytomegalovirus and Mechanisms of Desease. In: Reddehase MJ, editor. Cytomegaloviruses Molecular Biology and Immunology. Mainz: Caister Academic Press; 2006. p. 2-43.

  13. Townsend CL, Peckham CS, Tookey PA. Surveillance of congenital cytomegalovirus in the UK and Ireland. Arch Dis Child Fetal Neonatal Ed. 2011;96(6):398-403. Epub 2011/02/04.

  14. Mocarski ES, Shenk T, Pass R. Cytomegaloviruses. In: Howley PM, editor. Fields Virology. 5th Edition. Lippincott Williams & Wilkins; 2007. p. 2702-57.

  15. Kishore J, Misra R, Paisal A, Pradeep Y. Adverse reproductive outcome induced by Parvovirus B19 and TORCH infections in women with high-risk pregnancy. J Infect Dev Ctries. 2011;5(12):868-73. Epub 2011/12/16.

  16. Correa CB, Kouri V, Verdasquera D, Martinez PA, Alvarez A, Aleman Y, et al. HCMV Seroprevalence and associated risk factors in pregnant women. Havana city; 2007 to 2008. Prenat Deign. 2010;30:888-92.

  17. Barcelona C. Guías clínicas infecciones TORCH. Protocolo: Infecciones TORCH y por Parvovirus B19 en la gestación. Barcelona. 2011 [cited 2012 23/11]. Disponible en: http//www.medicinafetalbarcelona.org/clínica/images/p

  18. Delfin Harmant MA, Morandeira Abreu E, Domínguez Gómez J. Herpes Simple Genital. Disponible en: http://www.16deabril.sld.cu/rev/237/08.html

  19. Roizman B, Knipe DM, Whitley RJ. Herpes Simplex Viruses In: Knipe DM, Howley PM, editors. Fields Virology, 5th edition ed. Lippincott Williams & Wilkins; 2007. p. 2502-601.

  20. Sauerbrei A, Schmitt S, Scheper T, Brandstadt A, Saschenbrecker S, Motz M, et al. Seroprevalence of herpes simplex virus type 1 and type 2 in Thuringia, Germany, 1999 to 2006. Euro Surveill. 2011;16(44). Epub 2011/11/17.

  21. Tenorio A, Echevarría JE, Casas I, Echevarria JM, Tabares E. Detection and typing of human herpesviruses by multiplex polymerase chain reaction. Journal of Virological Methods. 1993;44:261-9.

  22. Shah SS, Aronson PL, Mohamad Z, Lorch SA. Delayed acyclovir therapy and death among neonates with herpes simplex virus infection. Matern Fetal Neonatal Med. 2011;128(6):1153-60.

  23. McGoogan KE, Haafiz AB, Gonzalez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011;159(4):608-11. Epub 2011/05/03.

  24. Al Midani A, Pinney J, Field N, Atkinson C, Haque T, Harber M. Fulminant hepatitis following primary herpes simplex virus infection. Saudi J Kidney Dis Transpl. 2011;22(1):107-11. Epub 2011/01/05.

  25. Mujugira A, Margaret A, Celum C, et al. Acyclovir and transmission of VHS-2 from VHS-2/HIV-1 dually infected persons. Quebec City; Canada: International Society for STD Research. 2011:P1–S5.25.




2020     |     www.medigraphic.com